Researchers at The Sahlgrenska Academy have now developed a method which identifies the Pancreatic cancer’s visible precursors with 97% certainty – Pancreatic cancer is often detected at a late stage, which results in poor prognosis and limited treatment options. Researchers at The Sahlgrenska Academy have now developed a method which identifies the cancer’s visible precursors with 97% certainty.
Smoking, heavy drinking linked to earlier onset of pancreatic cancer — University of Michigan Health System study makes step toward learning when cancer screenings should start – Those who smoke and drink heavily may develop pancreatic cancer at an earlier age than those who don’t. In a recent study, published in the American Journal of Gastroenterology, heavy smokers with pancreatic cancer were diagnosed around age 62 and heavy drinkers at age 61 ? almost a decade earlier than the average age of 72.
Sun exposure and sun-sensitive skin type decreased risk for pancreatic cancer – High levels of ultraviolet radiation at an individual’s birth location, sun-sensitive skin type and a history of skin cancer each decreased risk for pancreatic cancer, according to Australian researchers.
Scientists develop vaccine that attacks breast cancer in mice — Implications for the treatment of ovarian, colorectal and pancreatic cancer, as well – Researchers have developed a vaccine that dramatically reduces tumors in a mouse model that mimics 90 percent of human breast and pancreatic cancer cases-including those that are resistant to common treatments.
Research provides new kidney cancer clues — Gene is mutated in 1 in 3 patients with common form of renal cancer – Researchers have identified a gene that is mutated in one in three patients with the most common form of renal cancer. The identification of a frequently mutated gene will provide new insights into the biology of the disease.
A blood test for Alzheimer’s disease? – Using a new technology that relies on thousands of synthetic molecules to fish for disease-specific antibodies, researchers have developed a potential method for detecting Alzheimer’s disease with a simple blood test.
Surprise finding: Pancreatic cancers progress to lethal stage slowly – Pancreatic cancer develops and spreads much more slowly than scientists have thought, according to new research from Johns Hopkins investigators.
Pancreatic cancer: Researchers find drug that reverses resistance to chemotherapy – For the first time researchers have shown that by inhibiting the action of an enzyme called TAK-1, it is possible to make pancreatic cancer cells sensitive to chemotherapy, opening the way for the development of a new drug to treat the disease.
Eurand Granted FDA Approval for ZENPEP(TM) — First and Only FDA-Approved Pancreatic Enzyme Product Clinically Tested in Patients Under 12 Years Old. – U.S. Food and Drug Administration (FDA) has approved Eurand’s New Drug Application (NDA) for ZENPEP(TM) (pancrelipase) Delayed-Release Capsules for the treatment of exocrine pancreatic insufficiency (EPI) in patients with cystic fibrosis (CF) or other conditions.
Pancreatic cancer risk decreased by one anti-diabetic therapy, increased by others – The antidiabetic medication metformin is associated with a reduced risk of pancreatic cancer in diabetics, revealed by researchers. However, other commonly used therapies, such as insulin or insulin secretagogues, may be associated with increased risk.